Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shangxian Minimal Invasive is a China-based medical device company focused on the development, manufacturing, and marketing of gastrointestinal endoscopy and related minimally invasive products. The company appears to operate under the abbreviation SMI and sells endoscopic accessories as well as capsule endoscopy systems under its Shangxian brand, while also marketing anti-epidemic products under the Cleanday brand. Its portfolio includes hemoclips, biopsy forceps, injection needles, grasping forceps, polypectomy snares, distal caps, tip protectors, and capsule endoscopy hardware. The company positions itself as an endoscopic accessories manufacturer serving gastroenterology practice and exports across multiple global regions. Based on the available evidence, it is a commercial-stage medtech manufacturer rather than a drug-development biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shengxian Minimal Invasive.